Synonyms: ω-conotoxin MVIIA | Prialt® | SNX-111
ziconotide is an approved drug (FDA (2004), EMA (2005))
Compound class:
Peptide
Comment: Ziconotide is the INN for synthetically produced ω-conotoxin which was identified and extracted from the venom of Conus magus (Magus cone or Magician's cone snail).
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
No information available. |
Summary of Clinical Use ![]() |
Ziconotide (Prialt®) is an approved drug that is indicated for the management of severe chronic pain [6] in patients for whom intrathecal (IT) therapy is warranted and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or IT morphine. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
ω-conotoxins are selective N-type voltage-gated calcium channel (VGCC, Cav2.2) antagonists [1]. Ziconotide is a synthetic analogue of this naturally occurring compound. It behaves as a non-narcotic pain reliever, with its MMOA also attributable to VGCC blockade. Blocking the activity of these ion channels impedes excitatory neurotransmitter release in primary afferent nerve terminals and is antinociceptive [4]. |
External links ![]() |
For extended ADME data see the following: Drugs.com |